Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 7

Research Article

Safety and Efficacy of the C-117 Formula for Vulnerable Carotid Artery Plaques (Spchim): A Randomized Double-Blind Controlled Pilot Study

Table 7

Bilirubin levels of the two groups.

C-117 formula group (n=59) Placebo group (n=59) Z/TP

Total bilirubin (umol/L)

Before treatment10.74 ± 5.589.30 ± 2.64
After treatment11.08 ± 4.179.60 ± 2.32-1.6390.101

Direct bilirubin (umol/L)

Before treatment3.54 ± 1.563.20 ± 0.87
After treatment3.90 ± 1.243.54 ± 0.84-1.5610.119

Indirect bilirubin (umol/L)

Before treatment7.16 ± 4.176.06 ± 1.87
After treatment7.16 ± 3.106.06 ± 1.79-1.5870.112

M, mean ± standard deviation. P is the P value of the FAS dataset;
P<0.05 vs. before treatment.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.